KRAS and colorectal carcinoma: In DLD-1 and HCT116 CRC lines, both WT and KRASG13D were present, and when the G13D mutant allele was removed while keeping the WT KRAS, the top-down proteomics identified the nitrosylation of KRAS at C118 in more than 90% of the WT KRAS protein [79].